Coty consolidates
This article was originally published in The Rose Sheet
Executive Summary
Operations at Coty's Sanford, N.C. facility will be expanded in an effort to augment manufacturing and distribution capabilities, firm announces June 6. Specifically, the new operations will include "installation of four new state-of-the-art manufacturing lines" and expansion of the company's distribution capacity, Coty says. As a result, the firm will close its only other U.S. facility located in Mt. Olive, N.J. and consolidate operations into the expanded Sanford location. Coty will assist Mt. Olive's 200 employees in finding positions within the company, firm adds. The expanded Sanford facility and Mt. Olive transition is expected to be completed by the second or third quarter of 2007, according to Coty...
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.